Monika Noyszewska‐Kania

Serine Biosynthesis Pathway Supports MYC–miR-494–EZH2 Feed-Forward Circuit Necessary to Maintain Metabolic and Epigenetic Reprogramming of Burkitt Lymphoma Cells

Emilia Białopiotrowicz, Monika Noyszewska‐Kania, Neli Kachamakova‐Trojanowska et al. · Cancers · 2020 · 63 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism

Anna Polak, Emilia Białopiotrowicz, Beata Krzymieniewska et al. · Cell Death and Disease · 2020 · 41 citations · Full text

Life Sciences, Cancer Biology, Cell Biology +17

A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia

Wojciech Czardybon, Renata Windak, Aniela Gołas et al. · Oncotarget · 2018 · 36 citations · Full text

Medicine, Oncology, Pharmacology +14

Microenvironment‐induced <scp>PIM</scp> kinases promote <scp>CXCR</scp>4‐triggered <scp>mTOR</scp> pathway required for chronic lymphocytic leukaemia cell migration

Emilia Białopiotrowicz, Patryk Górniak, Monika Noyszewska‐Kania et al. · Journal of Cellular and Molecular Medicine · 2018 · 20 citations · Full text

Life Sciences, Cell Biology, Oncology +13

IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen

Marta Libura, Emilia Białopiotrowicz, Sebastian Giebel et al. · Scientific Reports · 2021 · 13 citations · Full text

Medicine, Genetics, Molecular Genetics +15